Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors |
Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer, Colorectal Cancer, Soft Tissue Sarcoma | Phase1 | Canada France Israel Singapore View all |
NCT07261631 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease |
Chronic Kidney Disease | Phase1 | Germany United States |
NCT07235059 |
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Phase1, Phase2 | Australia China France Germany Hong Kong Hungary South Korea Spain United States View all |
NCT07190300 |
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC |
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy | Phase1, Phase2 | Australia | NCT07226986 |
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation |
Atrial Fibrillation | Phase2 | Canada China Germany Netherlands Singapore United Kingdom United States View all |
NCT07217067 |
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Bulgaria Canada Czechia France Germany Malaysia Poland Singapore United States View all |
NCT07220577 |
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease |
Still´s Disease | Phase2 | Canada France Germany Italy Netherlands Spain Turkey (Türkiye) United States View all |
NCT07203001 |
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease |
Alzheimer's Disease | Phase2 | Australia Canada Czechia France Germany Japan Netherlands Poland South Korea Sweden United Kingdom United States View all |
NCT07094516 |
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors |
Small Cell Lung Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma | Phase1 | Canada South Korea United States |
NCT07006727 |
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS) |
PIK3CA-related Overgrowth Spectrum (PROS) | Phase2 | Australia Austria Belgium France Germany Italy Spain United States View all |
NCT06997588 |